Medical Suture Strength Retention Rate Testing: Standards, Methods and Applications

Medical suture strength retention rate testing evaluates how effectively absorbable and non-absorbable sutures maintain their tensile strength after exposure to simulated physiological conditions, providing critical data for wound-healing performance and regulatory compliance. This testing is essential for suture manufacturers, medical device developers, and regulatory submissions under standards such as ASTM, USP, ISO, and YY. This article explains the testing principle, sample requirements, test items, methodologies, and typical applications of strength retention rate testing for surgical sutures.

Technical Overview

Strength retention rate is a key performance indicator for surgical sutures, particularly absorbable sutures that gradually lose mechanical integrity as they degrade in body tissue. During the critical wound-healing period, a suture must retain sufficient tensile strength to hold tissue edges together; premature loss of strength can lead to wound dehiscence, while excessively slow degradation may cause extended foreign-body reaction.

Strength retention rate is defined as the ratio of the residual breaking strength of a suture measured after a defined exposure or degradation interval to its initial breaking strength, expressed as a percentage. The test is typically conducted by immersing suture specimens in a simulated body fluid such as phosphate buffered saline (PBS) at 37 ± 1 °C and pH 7.2–7.4, then periodically removing specimens to measure residual straight-pull or knot-pull tensile strength using a universal testing machine.

Testing is commonly performed in accredited third-party laboratories or in-house device laboratories in accordance with recognized standards, including ASTM F1635 (in vitro degradation testing of hydrolytically degradable polymers), USP General Chapter <881> on tensile strength of sutures, YY 0167 for non-absorbable surgical sutures, and YY 1116 for absorbable surgical sutures. Results support design verification, batch quality control, and regulatory submissions to agencies such as FDA, NMPA, and notified bodies under the EU MDR.

Testing Samples

Absorbable Sutures

Absorbable sutures are the primary subject of strength retention testing because their mechanical properties decline as hydrolysis or enzymatic degradation proceeds. Typical materials include polyglycolic acid (PGA), poly(lactic-co-glycolic acid) (PLGA), polydioxanone (PDO/PDS-type), poliglecaprone, polyglyconate, and surgical gut (plain and chromic). Both monofilament and braided (multifilament) constructions are tested, as construction type strongly influences degradation kinetics.

Non-Absorbable Sutures

Although non-absorbable sutures such as silk, nylon, polyester, polypropylene, and stainless steel are expected to retain strength indefinitely, retention testing may still be requested to verify resistance to hydrolysis, sterilization effects, or long-term storage. These studies are frequently integrated into shelf-life and packaging validation programs.

Specialty and Constructed Samples

Barbed (knotless) sutures, antimicrobial-coated sutures, drug-eluting sutures, and crimped needle-suture attachments can also be evaluated. Sample preparation requirements typically include:

• Specimens cut to specified lengths with adequate gauge length for tensile gripping (commonly 100–150 mm between grips).
• Knot-pull specimens tied with a standardized knot type (e.g., surgeon's knot) and specified throw count.
• Diameter measurement of each specimen before testing, since strength values are normalized per USP size class.
• Adequate replicate counts (commonly 5–10 specimens per time point) for statistical reliability.
• Documentation of lot number, sterilization method (ethylene oxide, gamma, e-beam), and storage history.

Testing Items

Core and supplementary test items for a comprehensive strength retention evaluation include:

• Straight-pull tensile strength (baseline and residual): maximum force required to rupture an unknotted suture.
• Knot-pull tensile strength: maximum force to rupture a knotted specimen, reflecting real-world clinical performance.
• Strength retention rate at each degradation interval: residual strength divided by initial strength, expressed as a percentage.
• Time-to-threshold analysis: determination of the exposure duration at which strength falls below a specification limit (e.g., 50% or 25% retention).
• Supplementary degradation metrics: mass loss, diameter change, pH drift of the immersion medium, and inherent viscosity or molecular weight for polymeric sutures.
• Failure mode observation: breakage location, fraying of braided constructs, or knot slippage recorded during tensile testing.

Testing Methods

Baseline Strength Determination

Initial tensile strength is measured on as-received specimens in the dry state (or conditioned state as specified) using a calibrated universal testing machine with an appropriate load cell resolution, following USP <881> or equivalent pharmacopoeial practice. Gauge length, crosshead speed (commonly 25–300 mm/min depending on size and standard), and grip type (pneumatic or capstan grips to avoid slippage) are controlled and recorded.

In Vitro Degradation Exposure

Specimens are immersed in phosphate buffered saline maintained at 37 ± 1 °C and pH 7.2–7.4 in accordance with ASTM F1635 methodology. Key controls include solution-to-sample volume ratio, container closure integrity, periodic pH verification, and solution replacement schedules. Defined retrieval time points—commonly 1, 2, 3, 4, and up to 8 weeks, or day 3/7/14/21/28 sequences—are established based on the material's expected absorption profile.

Residual Strength Measurement and Calculation

At each time point, specimens are removed, gently blotted, and tested within a defined post-retrieval window to avoid drying artifacts. The strength retention rate is calculated as follows:

• Retention Rate (%) = (Mean residual tensile strength at time t ÷ Mean initial tensile strength) × 100.
• Results are reported with standard deviation, coefficient of variation, and a retention-versus-time curve.

Standards and Compliance References

Testing protocols may be structured with reference to ASTM F1635, USP <881>, YY 0167, YY 1116, GB/T 16886 series for biological evaluation context, and ISO 10993 where biocompatibility interfaces with degradation assessment. In vivo confirmation studies in animal models remain a regulatory expectation for certain absorbable suture claims, with in vitro data serving as the primary screening and lot-release tool.

Applications

Strength retention rate testing supports multiple stages of the suture product lifecycle:

• Design and development: screening polymer formulations, coatings, and braiding constructions to achieve target absorption profiles.
• Process validation: verifying that extrusion, braiding, annealing, and sterilization parameters do not unduly accelerate strength loss.
• Quality control and batch release: confirming conformance to pharmacopoeial and enterprise specifications for breaking strength retention.
• Regulatory submissions: generating technical evidence for FDA 510(k)/PMA files, NMPA registration dossiers, and EU MDR technical documentation.
• Shelf-life and stability studies: assessing long-term storage effects on mechanical performance.
• Comparative and equivalence studies: benchmarking candidate sutures against predicate devices in support of marketing claims.

FAQ

What is a typical acceptance criterion for strength retention of absorbable sutures?

Acceptance limits depend on material class and intended clinical support period. As a general principle, absorbable sutures must retain a substantial fraction of initial strength through the critical healing window (often 7–14 days), with specified minimum retention values at defined time points established in product standards and manufacturer specifications.

Why is 37 °C phosphate buffered saline used?

The conditions simulate the hydrolytic environment, temperature, and pH of human physiological tissue, providing a reproducible and ethically preferable alternative to immediate animal testing for degradation screening.

How many specimens are required per time point?

A typical protocol uses five to ten replicates per time point for both straight-pull and knot-pull configurations, with the total specimen count determined by the number of planned retrieval intervals and statistical requirements.

Can in vitro results fully replace in vivo studies?

No. In vitro retention data are highly valuable for development and lot screening, but in vivo enzymatic activity, tissue pH variation, and mechanical loading differ from buffered immersion. Regulatory authorities often expect confirmatory in vivo studies for absorbable suture performance claims.

What equipment is used?

A calibrated universal tensile testing machine with precision load cells, temperature-controlled incubation baths or chambers, pH meters, and optical or laser micrometers for diameter measurement form the core instrumentation in accredited third-party laboratories and device test facilities.